Hypothalamic Hypogonadotropic Hypogonadism in an Adolescent Male: A Rare Manifestation of Aqueductal Stenosis by Wilson, Robert J. & Wisgerhof, Max
Henry Ford Hospital Medical Journal 
Volume 35 Number 4 Article 3 
12-1987 
Hypothalamic Hypogonadotropic Hypogonadism in an 
Adolescent Male: A Rare Manifestation of Aqueductal Stenosis 
Robert J. Wilson 
Max Wisgerhof 
Follow this and additional works at: https://scholarlycommons.henryford.com/hfhmedjournal 
 Part of the Life Sciences Commons, Medical Specialties Commons, and the Public Health Commons 
Recommended Citation 
Wilson, Robert J. and Wisgerhof, Max (1987) "Hypothalamic Hypogonadotropic Hypogonadism in an 
Adolescent Male: A Rare Manifestation of Aqueductal Stenosis," Henry Ford Hospital Medical Journal : 
Vol. 35 : No. 4 , 181-184. 
Available at: https://scholarlycommons.henryford.com/hfhmedjournal/vol35/iss4/3 
This Article is brought to you for free and open access by Henry Ford Health System Scholarly Commons. It has 
been accepted for inclusion in Henry Ford Hospital Medical Journal by an authorized editor of Henry Ford Health 
System Scholarly Commons. 
hypothalamic Hypogonadotropic Hypogonadism in an Adolescent 
I^ ale: A Rare Manifestation of Aqueductal Stenosis 
Robert J. Wilson, MD,* and Max Wisgerhof, MD* 
at nonphar-
of severely 
nal changes , 
es meUitus. ' 
experience i 
lis observa-
1 A. Block, 
•gery and a 
' Endocrine i 
le Journal \ 
ition by Dr. 
Did disease. 
Congenital stenosis of the aqueduct of Sylvius accounts for most cases of hydrocephalus diagnosed during infancy and 
early childhood (1,2). Enlargement of the skull and progressive 
neurological symptoms early in life usually suggest the di-
agnosis (2). With lesser degrees of obstruction, the disorder 
may not become apparent until adolescence or adulthood (2,3). 
Decompensation of the hydrocephalus is heralded by a symp-
tom complex which includes intellectual impairment, head-
aches, visual disturbances, seizures, and unsteady gait (3-6). 
Approximately one half of the patients will have papilledema at 
presentation (3,4). Reduction of the hydrocephalus by ven-
tricular cerebrospinal fluid (CSF) shunt procedures can alleviate 
the neurologic abnormalities (3,4,6). 
Although the presence of neuroendocrine abnormalities in 
a small subset of adolescent or adult patients with aqueductal 
stenosis has been reported (2-5,7,8), aqueductal stenosis pre-
senting as pure endocrine dysfunction without neurologic ab-
normality has been only sporadically described in the literature 
(9-11). No reports have detailed a male presenting in this latter 
fashion. The endocrine abnormalities are ascribed to hypotha-
lamic-pituitary dysfunction resulting from pressure on the 
liypothalamus exerted by the expanded end of the third ventricle 
(12). Pituitary function is usually restored by ventricular CSF 
shunt procedures (9,11). 
We report a case of an adolescent male with aqueductal ste-
nosis whose presenting complaints were short stature and puber-
tal arrest, without neurologic abnormalities. Hormone testing 
demonstrated partial hypopituitarism secondary to hypotha-
lamic dysfunction. Decompression of the hydrocephalus re-
versed the clinical and laboratory abnormalities. 
Case Report 
A 17-year-old white male was referred to us for evaluation of arrested 
pubertal development and decelerating linear growth. His growth and 
tlevelopment had been normal until age 10. His attenuated growth, 
shown by a deviation from his centile channel for height, was first de-
tected at age 13 (Fig 1). By age 16 he had stopped growing, and his 
lieight was markedly below normal. Initial pubertal changes occurred at 
13, but had not progressed beyond scant axillary and pubic hair 
growth. He felt well, was physically active, and received average 
grades in a school class appropriate to his age. He denied headaches, 
seizures, visual disturbances, or clumsiness. 
The patient was mildly obese, appeared prepubertal, was 158 cm tall, 
Id Weighed 43.5 kg. He was normocephalic and had normal pupils and 
°Ptic fimdi. Genitalia (testicular length 2 cm) and axillary and pubic 
hair were Tanner Grade II. The results of the neurological examination, 
including Goldmann visual fields, were normal. Skeletal age, as inter-
preted from hand radiographs, was consistent with the standards for a 
14-year-old boy. 
Because the patient's puberty began normally then ceased pre-
maturely, and because his short stature had resulted from a deceleration 
in linear growth, an acquired disorder was suspected. The differen-
tial diagnosis included hypothyroidism, Cushing's syndrome, and 
hypopituitarism. 
Endocrine testing data excluded hypothyroidism, Cushing's syn-
drome, and growth hormone deficiency. The data, however, revealed 
that his testosterone concentration was low and that his luteinizing hor-
mone secretion responded briskly to gonadotropin-releasing hormone 
(Table). These results demonstrated that his pituitary gland was intact 
and suggested that the secretion of gonadotropin-releasing hormone 
from his hypothalamus was impaired, resulting in hypothalamic hypo-
gonadotropic hypogonadism. 
STATURE 
Icml 
Fig 1—Cumulative growth chart showing curve of attenuated 
growth with growth arrest and short stature, and changes in 
body weight. 
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Fig 2—Computed tomography of brain (transverse section) at 
the level ofthe sella demonstrates ballooning ofthe third ventri-
cle into the sella. 
Computed tomography of the head was performed to detect a 
suprasellar mass such as a craniopharyngioma. It revealed marked in-
temal hydrocephalus which had distended the lateral and third ventri-
cles and herniated the third ventricle into an enlarged sella turcica (Fig 
2). The fourth ventricle was nonnal, and a mass was not present. High-
resolution computed tomography of the sella showed marked thinning 
and erosion of the floor of the pituitary fossa. Nuclear magnetic reso-
nance imaging excluded the presence of a mass obstructing the aque-
duct of Sylvius and showed that the pituitary gland and its stalk were 
nonnal (Fig 3). These findings established the diagnosis of hydro-
cephalus caused by stenosis of the aqueduct of Sylvius. Compression of 
the hypothalamus by the hydrocephalic third ventricle was postulated as 
the cause of the patient's arrested growth and puberty. 
A ventricular-peritoneal shunt was perfonned to reduce the hydro-
cephalus. By five weeks after surgery, the patient had observed an 
increase in sweating and in facial, axillary, and pubic hair growth. 
Computed tomography showed a marked reduction of the hydro-
cephalus. Ten weeks after surgery, he reported the onset of nocturnal 
Fig 3—Nuclear magnetic resonance of the head (midline sagit-
tal section) reveals the stenotic proximal portion ofthe aqueduct 
of Sylvius (arrow) with enlarged third ventricle and a normal-
sized fourth ventricle. 
emissions and tender gynecomastia. By three months after surgery, his 
testicles had increased in size to 3 cm, his pubic hair was classified as 
Tanner Grade IV, and his height had increased by 1 cm. The ratio of 
luteinizing hormone to follicle-stimulating hormone had reversed, and 
serum testosterone levels had increased consistent with pubertal matu-
ration (Table). 
Discussion 
Aqueductal stenosis presenting in adolescence and adulthood 
is not rare (2) and has five general groups of presentation; intel-
lectual impairment, headache, seizures, visual disturbance, and 
gait disturbance (3-7). Concomitant endocrine abnormalities 
Table 
Endocrine Studies: Preoperative and Postoperative Data 
Indice Preoperative 
Postoperative 
4 Months 10 Months 
Normal Values 
for 
Pubertal Male 
Testosterone (ng/dL) 30 260 410 300-1,000 
Basal LH ((j,IU/mL) 5 8 
— 
4-23 
LH after IOO jig GnRH (M,IU/mL) 44 
— — 
increment > 16 
Basal FSH ((jilU/ml,) 7 5 
— 
1.5-19 
Peak growth hormone 
(ng/mL) after: 
Bromocriptine (2.5 mg) 11 4.7 
— 
f > 7 ng/dL 
Insulin (O.I U/kg) 
— 
IX 
— 
\ > 1 ng/dL 
Somatomedin-C (U/mL) 1,6 2.3 
— 
0.9-3.1 
(15-18 years) 
Prolactin (ng/mL) 13 17 
— 
< 25 
T4, total thyroxine (jig/dL) 6.8 6.2 6 5-11 
Basal TSH ((jiIU/mL) 1.7 1.2 
— 
< 7.5 
TSH after IOO jig TRH ((ilU/mL) 9.2 6.1 
— 
increment > 6 
Plasma AM Cortisol ((ig/dL) 15 17 
— 
8-28 
DHEA sulfate (ng/dL) 1,300 1,300 1,100 1,990-3,350 
LH = luteinizing hormone. GnRH = gonadotropin-releasing hormone. FSH = follicle-stimulating hormone, TSH = thyroid-
stimulating hormone, TRH = thyrotropin-releasing hormone, and DHEA = dehydroepiandrosterone. 
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Mch as amenorrhea, delayed or precocious puberty, short stat-
obesity, hypothyroidism, and diabetes insipidus have been 
floted in the older literature. One study reported symptoms sug-
ggsove of endocrine defects in 10% of patients presenting with 
jqueductal stenosis (3), but clearly documented reports of endo-
j.fine deficiency are few and mainly describe females with 
tiypothalamic amenorrhea (8-11,13-17), The predilection for 
jjdocrine abnormalities in females with aqueductal stenosis is 
gf interest (8) because this condition occurs with about equal 
frequency in males and females (2-4). Furthermore, the recent 
literature reveals only three documented cases of endocrine dis-
turbances in adolescent or adult males: one with isolated growth 
bomione deficiency, a second with gonadotropin deficiency and 
short stature, and a third with short stature and pubertal delay 
(12-14). All three presented with neurologic abnormalities that 
prompted investigation and diagnosis. The endocrine abnor-
0ialities were subsequently recognized. In two patients, regres-
sion of the endocrine abnormalities occurred following CSF 
drainage procedures (13,14). 
Our patient's case is unusual as he is one of the few males re-
ported to have an endocrine abnormality in the setting of aque-
ductal stenosis (12-14). Moreover, to the best of our knowledge, 
this is the first case of aqueductal stenosis in a male who pre-
sented with endocrine dysfunction without neurologic abnor-
mality. The investigation of pubertal arrest and short stature in 
our patient led to the documentation of hypogonadism and 
culminated in the discovery of aqueductal stenosis. Ventricular-
peritoneal shunting has decompressed the hydrocephalus which 
resulted from the aqueductal stenosis and has led to the reversal 
of the endocrine abnormality. 
Nuclear magnetic resonance imaging in adult patients with 
aqueductal stenosis has been previously reported (18), but this 
application in aqueductal stenosis with only endocrine dysfunc-
tion is unique. It contributed to an accurate diagnosis in our case 
by excluding the presence of a tumor compressing the aqueduct. 
Unlike patients with communicating hydrocephalus, who 
rarely have endocrine abnormalities (19), patients with aqueduc-
tal stenosis appear to be at risk for these abnormalities. This is 
because the disproportionate enlargement of the anterior end 
of the third ventricle leads to pressure-induced dysfunction of 
the hypothalamic-pituitary axis (12,20). The neural pulse 
generators of gonadotropin-releasing hormone and growth hor-
mone-releasing hormone are located in the medial hypothalamic 
neurons and are necessary for normal gonadotropin and growth 
bormone release (21). In aqueductal stenosis with hydro-
cephalus, the function of these pulse generators is presumably 
'mpaired by pressure from the hydrocephalus. 
The preponderance of females in reports of endocrine man-
ifestations of aqueductal stenosis indicates that the female 
''ypothalamic-pituitary-gonadal axis is either more sensitive to 
uydrocephalus than the male axis or that hypogonadal dysfunc-
tion in males may be present but not recognized. The failure of 
^adolescent female to menstmate or the cessation of menses in 
* young adult female are dramatic signposts of endocrine dys-
^ction. Pubertal development in a male lacks such a discrete 
e^ ent heralding the completion of puberty, and signs and symp-
'oins of male hypogonadism may be more easily missed. The 
Serious neurologic abnormalities usually noted at presentation in 
i&Wisgs*' '^ "iryFordH osp Med J—Vol 35, No 4, 1987 
patients with aqueductal stenosis may fiuther obscure endocrine 
dysfunction in males. 
The lack of neurologic abnormalities in our patient with aque-
ductal stenosis is noteworthy but unexplained. Only his arrested 
pubertal development and short stature brought him to medical 
attention. A plot of the patient's height on growth charts demon-
strated a deceleration of linear growth velocity and suggested 
that the aqueductal stenosis had led to endocrine dysfunction at 
least four years before we first saw him. Patients with aqueductal 
stenosis have been reported to remain only mildly symptomatic 
for extended periods and then suddenly develop symptoms of 
decompensated hydrocephalus and signs of increased intra-
cranial pressure (22). 
The reversal of endocrine abnormalities by ventricular CSF 
shunting, as demonstrated in our patient, is well recorded 
(7,9,11,13-15,23,24). This apparently reflects the decompres-
sion of the internal hydrocephalus and release of downward 
pressure on the hypothalamus and pituitary. Reversal of endo-
crine dysfunction has been documented as early as one month 
(11) and as late as five years (8) after surgery, with most re-
sponses occurring within one year (8,9,14,22). 
Our patient responded to surgery with an early and dramatic 
resumption in pubertal development, paralleled by increases 
in serum testosterone. His pubertal maturation has continued 
during the past I I months since his surgery. His resumption 
of growth has been less dramatic; no pubertal growth spurt has 
been noted. While his somatomedin-C levels are adequate, 
a neurosecretory disorder of growth hormone release may be 
present. This was suggested after surgery by a failure of growth 
hormone levels to rise following the administration of bromo-
criptine. Further observation over time may document a 
spontaneous increase in growth velocity. However, a trial of 
growth hormone may be warranted in the future if bone age pro-
gresses in the face of suboptimal growth rate. 
Conclusions 
Decelerating linear growth and arrest of puberty present 
a challenging differential diagnosis, ranging from treatable 
idiopathic disorders to reversible specific pathology. We have 
expanded this differential diagnosis in the male to include 
aqueductal stenosis. This disorder should be considered in pa-
tients of any age who have hypothalamic hypogonadotropic 
hypogonadism. 
Aqueductal stenosis can be readily detected by computed to-
mography of the brain. Nuclear magnetic resonance imaging 
improves diagnostic accuracy through its sensitivity in detecting 
cystic and solid tumors obstructing the aqueduct. Ventricular 
CSF shunting of the hydrocephalus of aqueductal stenosis can 
restore normal endocrine function and prevent serious neu-
rologic sequelae of this disorder. 
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